메뉴 건너뛰기




Volumn 18, Issue 26, 2011, Pages 3953-3962

Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines

Author keywords

Adjuvant; AIDS; Chemokines; CTL; Cytokines; Dendritic cells; Epitope; HIV 1; Innate immunity; Mucosal immunity; Peptide; Systemic immunity; T lymphocyte; TLR ligands; Vaccine

Indexed keywords

CHOLERA TOXIN; CYTOKINE; DNA VACCINE; GAG PROTEIN; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; HLA ANTIGEN CLASS 2; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOLOGICAL ADJUVANT; MODIFIED VACCINIA VIRUS ANKARA VECTOR; NEF PROTEIN; PEPTIDE VACCINE; POL PROTEIN; POLYPEPTIDE; RECOMBINANT VACCINE; TOLL LIKE RECEPTOR 2 LIGAND; TOLL LIKE RECEPTOR 3 LIGAND; TOLL LIKE RECEPTOR 6 LIGAND; TOLL LIKE RECEPTOR 9 LIGAND; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

EID: 80052214240     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711796957293     Document Type: Article
Times cited : (8)

References (159)
  • 22


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.